Skip to main content

Stratified Breast Cancer Follow-Up Using a Partially Observable MDP

  • Chapter
  • First Online:

Part of the book series: International Series in Operations Research & Management Science ((ISOR,volume 248))

Abstract

Frequency and duration of follow-up for patients with breast cancer is still under discussion. Current follow-up consists of annual mammography for the first five years after treatment and does not depend on the personal risk of developing a locoregional recurrence (LRR) or second primary tumor. Aim of this study is to gain insight in how to allocate resources for optimal and personal follow-up. We formulate a discrete-time Partially Observable Markov Decision Process (POMDP) with a finite horizon in which we aim to maximize the total expected number of quality-adjusted life years (QALYs). Transition probabilities were obtained from data from the Netherlands Cancer Registry (NCR). Twice a year the decision is made whether or not a mammography will be performed. Recurrent disease can be detected by both mammography or women themselves (self-detection). The optimal policies were determined for three risk categories based on differentiation of the primary tumor. Our results suggest a slightly more intensive follow-up for patients with a high risk and poorly differentiated tumor, and a less intensive schedule for the other risk groups.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. W.L. Lu, L. Jansen, W.J. Post, J. Bonnema, J.C. van de Velde, G.H. De Bock, Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res. Treat. 114, 403–412 (2009). http://dx.doi.org/10.1007/s10549-008-0023-4

    Article  Google Scholar 

  2. M. Moossdorff, L.M. van Roozendaal, L.J.A. Strobbe, S. Aebi, D.A. Cameron, J.M. Dixon, A.E. Giuliano, B.G. Haffty, B.E. Hickey, C.A. Hudis, V.S. Klimberg, B. Koczwara, T. Kühn, M.E. Lippman, A. Lucci, M. Piccart, B.D. Smith, V.C.G. Tjan-Heijnen, C.J.H. van de Velde, K.J.V. Zee, J.B. Vermorken, G. Viale, A.C. Voogd, I.L. Wapnir, J.R. White, M.L. Smidt, Maastricht Delphi consensus on event definitions for classification of recurrence in breast cancer research. J. Natl. Cancer Inst. 106 (12), 1–7 (2014). http://dx.doi.org//10.1093/jnci/dju288

  3. IKNL, Dutch Breast Cancer Guideline (2016), available: https://www.oncoline.nl/ [Online]. Accessed 2 March 2016

  4. S.M.E. Geurts, F. de Vegt, S. Siesling, K. Flobbe, K.K.H. Aben, M. van der Heiden-van der Loo, A.L.M. Verbeek, J.A.A.M. van Dijck, V.C.G. Tjan-Heijnen, Pattern of follow-up care and early relapse detection in breast cancer patients. Breast Cancer Res. Treat. 136, 859–868 (2012). http://dx.doi.org/10.1007/s10549-012-2297-9

    Article  Google Scholar 

  5. A. Witteveen, I.M.H. Vliegen, G.S. Sonke, J.M. Klaase, M.J. IJzerman, S. Siesling, Personalisation of breast cancer follow-up: a time-dependent prognostic nomogram for the estimation of annual risk of locoregional recurrence in early breast cancer patients. Breast Cancer Res. Treat. 152, 627–636 (2015). http://dx.doi.org/10.1007/s10549-015-3490-4

    Article  Google Scholar 

  6. M. IJzerman, A. Manca, J. Keizer, S. Ramsey, Implementing comparative effectiveness research in personalized medicine applications in oncology: current and future perspectives. Comp. Eff. Res. 26 (5), 65–72 (2015). https://dx.doi.org/10.2147/CER.S92212

    Google Scholar 

  7. R.D. Smallwood, E.J. Sondik, The optimal control of partially observable Markov processes over a finite horizon. Oper. Res. 21 (5), 1071–1088 (1973). http://dx.doi.org/10.1287/opre.21.5.1071

    Article  Google Scholar 

  8. L.N. Steimle, B.T. Denton, Markov decision processes for screening and treatment of chronic diseases, in Markov Decision Processes in Practice, ed. by R. Boucherie, N.M. van Dijk (Springer, New York, 2016)

    Google Scholar 

  9. T. Ayer, O. Alagoz, N.K. Stout, A POMDP approach to personalize mammography screening decisions. Oper. Res. 60 (5), 1019–1034 (2012). http://dx.doi.org/10.1287/opre.1110.1019

    Article  Google Scholar 

  10. M.U.S. Ayvaci, O. Alagoz, E.S. Burnside, The effect of budgetary restrictions on breast cancer diagnostic decisions. MSOM 14 (4), 600–617 (2012). http://dx.doi.org/10.1287/msom.1110.0371

    Article  Google Scholar 

  11. J. Zhang, B.T. Denton, H. Balasubramanian, N.D. Shah, B.A. Inman, Optimization of PSA screening policies: a comparison of the patient and societal perspectives. Med. Decis. Making 32 (1), 337–349 (2012). http://dx.doi.org/10.1177/0272989X11416513

    Article  Google Scholar 

  12. F.A. Sonnenberg, J.R. Back, Markov models in medical decision making, a practical guide. Med. Decis. Making 13 (4), 322–338 (1993). http://dx.doi.org/10.1177/0272989X9301300409

    Article  Google Scholar 

  13. G.E. Monahan, A survey of partially observable Markov decision processes: theory, models and algorithms. Manag. Sci. 28 (1), 1–16 (1982). http://dx.doi.org/10.1287/mnsc.28.1.1

    Article  Google Scholar 

  14. W.S. Lovejoy, A survey of algorithmic methods for partially observed Markov decision processes. Ann. Oper. Res. 28 (1), 47–65 (1991). http://dx.doi.org/10.1007/BF02055574

    Article  Google Scholar 

  15. J.N. Eagle, The optimal search for a moving target when the search path is constrained. Oper. Res. 32 (5), 1107–1115 (1984). http://www.jstor.org/stable/170656

    Article  Google Scholar 

  16. CBS, Statline (2016), available: http://statline.cbs.nl/Statweb/ [Online]. Accessed 18 May 2016

  17. Netherlands Comprehensive Cancer Organisation (IKNL), Netherlands Cancer Registry (2016), available: https://www.cijfersoverkanker.nl/ [Online]

  18. J.S. Mandelblatt, M.E. Wheat, M. Monane, R.D. Moshief, J.P. Hollenberg, J. Tang, Breast cancer screening for elderly women with and without comorbid conditions: a decision analysis model. Ann. Internal Med. 116 (9), 722–730 (2002). http://dx.doi.org/10.7326/0003-4819-116-9-722

    Article  Google Scholar 

  19. V. Velanovich, Immediate biopsy versus observation for abnormal findings on mammograms: an analysis of potential outcomes and costs. Am. J. Surg. 170 (4), 327–332 (1995). http://dx.doi.org/10.1016/S0002-9610(99)80298-0

  20. T.M. Kolb, J. Lichy, J.H. Newhouse, Comparison of the performance of screening mammography, physical examination, and breast us and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 225, 165–175 (2002). http://dx.doi.org/10.1148/radiol.2251011667

    Article  Google Scholar 

  21. WHO, The world health report: 2002: reducing risks, promoting healthy life. World Health Organization (2002)

    Google Scholar 

  22. M. Fine, B. Rimer, P. Watts, Women’s responses to the mammography experience. J. Am. Board Fam. Pract. 6 (6), 546–555 (1993)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Witteveen .

Editor information

Editors and Affiliations

Appendix: Notation

Appendix: Notation

General

This chapter

Description

S

S

State space

s

s t

State at time t

r

r t (s, a, o)

Reward at time t in state s with action a and observation o

A

A t

Set of actions at time t

a

a t

Action at time t

P

P t (a, o)

Transition probability at time t given action a

  

and observation o

V t (s)

V t (π), V t (b)

Optimal value function from time t onwards given

  

information state π or belief state b

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Otten, J.W.M., Witteveen, A., Vliegen, I.M.H., Siesling, S., Timmer, J.B., IJzerman, M.J. (2017). Stratified Breast Cancer Follow-Up Using a Partially Observable MDP. In: Boucherie, R., van Dijk, N. (eds) Markov Decision Processes in Practice. International Series in Operations Research & Management Science, vol 248. Springer, Cham. https://doi.org/10.1007/978-3-319-47766-4_7

Download citation

Publish with us

Policies and ethics